Form 4: Voyager Therapeutics COO Robin Swartz Sells Shares

Robin Swartz, COO & CBO of Voyager Therapeutics, sold 6,500 shares of common stock at an average price of $5.65 on December 23, 2024.

Summary

• Robin Swartz, the COO & CBO of Voyager Therapeutics, sold 6,500 shares of common stock on December 23, 2024.
• The shares were sold at a weighted average price of $5.65, with individual transactions ranging from $5.62 to $5.70.
• Following the transaction, Swartz directly owns 112,328 shares of Voyager Therapeutics.
• This total includes 1,824 shares acquired through the company's Employee Stock Purchase Plan on June 28, 2024.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine disclosure of an insider stock sale. The size of the sale is not significant enough to cause alarm, but it's worth noting.

Industry Context

This is a routine disclosure of an insider stock transaction. It's common for executives to periodically sell shares for personal financial management. The impact on the stock depends on the size of the sale relative to the executive's holdings and the overall market sentiment.

Stakeholder Impact

• The sale could have a minor negative impact on shareholder sentiment if interpreted negatively, but the size of the transaction is unlikely to cause significant concern.

Key Dates